Reprogramming the immune system, restoring lives
COUR Pharma (courpharma.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 40th percentile of 17552 Healthcare brands.
COUR Pharma is a biopharmaceutical company focused on developing targeted immunotherapies for autoimmune diseases, including Type 1 Diabetes. Using an immune system reprogramming platform, the company designs antigen-specific treatments intended to restore immune tolerance and address the underlying causes of autoimmune conditions rather than merely managing symptoms. COUR positions itself as a pioneer in this therapeutic approach, building a diverse pipeline aimed at transforming care for patients, while also engaging healthcare providers, researchers, and biopharmaceutical partners in its efforts to reprogram the immune system and restore patient health.
| Brand Name | COUR Pharma |
|---|---|
| Domain | courpharma.com |
| Industry | Healthcare |
| Main Competitors | Anokion (51/100), Parvus Therapeutics (75/100), Selecta Biosciences, Provention Bio (76/100), Pandion Therapeutics (45/100) |
Moz Domain Authority 33/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ..." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram; no detected presence on LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
COUR Pharma's main competitors in Healthcare: Anokion (51/100), Parvus Therapeutics (75/100), Provention Bio (76/100), Pandion Therapeutics (45/100).
Sources: Brand Analyzer scan
COUR Pharma has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 38, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: COUR Pharma official site
COUR Pharma scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: COUR Pharma official site
COUR Pharma is a biopharmaceutical company developing targeted immunotherapies designed to restore immune tolerance in patients with autoimmune diseases.
Sources: COUR Pharma official site
COUR Pharma develops antigen-specific immune therapies that aim to reprogram the immune system, addressing the root causes of autoimmune diseases such as Type 1 Diabetes rather than just treating symptoms.
Sources: COUR Pharma official site
COUR Pharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: COUR Pharma official site
COUR Pharma offers targeted immunotherapies designed to treat autoimmune diseases, including candidates aimed at Type 1 Diabetes, through its antigen-specific immune reprogramming platform.
Sources: COUR Pharma official site
COUR Pharma is known for pioneering antigen-specific immunotherapy technology aimed at restoring immune tolerance in autoimmune disease patients.
Sources: COUR Pharma official site
COUR Pharma's therapies and research are intended for patients with autoimmune diseases such as Type 1 Diabetes, and the company engages with healthcare providers, researchers, and biopharmaceutical partners.
Sources: COUR Pharma official site
COUR Pharma scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
COUR Pharma has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 33/100.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to COUR Pharma: Cosucra (74/100), CorVista (74/100), Covera Health (74/100), Coviu (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.